Javascript is not enabled.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.

Skip to content
Content starts here
CLOSE ×
Search
CLOSE ×
Search
Leaving AARP.org Website

You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.

Caregiving for Frontotemporal Dementia: What Families Need to Know

Caregivers often first notice subtle changes in behavior, personality or speech — rather than memory loss — as the earliest warning signs


Debra and Chris Tann
Debra and Chris Tann have become advocates for raising awareness about frontotemporal dementia after Chris was diagnosed in 2019.
Audra Melton

When Emma Heming Willis first noticed subtle changes in her husband, Hollywood actor Bruce Willis, 70, she could not have imagined they were early signs of an often-misunderstood form of dementia. What began as small shifts in language and behavior gradually revealed itself as frontotemporal dementia (FTD), a diagnosis that would upend their family’s life and thrust Heming Willis, now 47, into an unanticipated role as caregiver.​

By choosing to share her family’s story, Heming Willis has helped bring unprecedented attention to FTD, a condition that often strikes earlier than Alzheimer’s and is marked by changes in speech, behavior or personality rather than early memory loss. Talk show host Wendy Williams, 61, has also further amplified public awareness after it was announced that she was diagnosed in 2023. ​

Through her book, The Unexpected Journey, Heming Willis has transformed private hardship into public education, telling AARP during her 2025 media tour that she hoped her book would serve as a map for people navigating their unexpected journey. “What I love about the book is that you can just open it up at any point, read a paragraph and take something away from it.”​

​Like most families, Chris and Debra Tann of Valdosta, Georgia, were not expecting to hear Chris’s diagnosis of FTD in 2019. Drawing on her training as a certified dementia educator, Debra, 66, pushed for further evaluation, ultimately securing specialized care for Chris, 70, at Vanderbilt University. There, Chris’s diagnosis was confirmed and he eventually decided to participate in a five-year study to observe his symptoms and physical and emotional changes. Debra also helped him connect with The Association for Frontotemporal Degeneration, where he currently serves on an advisory council. He also participates in the Black Dementia Minds support group. ​

“The diagnosis was devastating, but it also gave us clarity. Suddenly, behaviors that felt confusing and painful made sense, and that understanding changed how we moved forward,” says Debra, author of The Race of Dementia. “Once we understood what we were dealing with, we stopped asking, ‘Why is this happening?’ and started asking, ‘How do we live well with this?’ ”​

two people sitting together at a table
The Tanns live in Georgia, where Debra works tirelessly to advocate for caregivers, debunk myths and erase stigma associated with dementia.
Audra Melton

What makes frontotemporal dementia different

Frontotemporal dementia (FTD) is less widely recognized than Alzheimer’s disease, but it is often more disruptive for families because it strikes at the core of who a person is. The disease originates in the frontal and temporal lobes of the brain, areas that govern impulse control, social behavior, empathy, self-awareness and communication.​

When the frontal lobes are affected, people may exhibit poor judgment, personality changes, loss of inhibition and difficulty with planning and decision-making. Damage to the temporal lobes can impair language and emotional processing, leading to primary progressive aphasia, a form of FTD, and problems with understanding words, recognizing social cues and processing meaning.​

“Frontotemporal dementia typically presents as either progressive problems of language or abnormal behavior,” says Dr. S. Ahmad Sajjadi, chief of the memory disorders division, department of neurology at UCI Health in Irvine, California. “Since both presentations can also infrequently happen in the context of Alzheimer’s disease, there is a chance for misdiagnosis.”​

FTD is also notable for who it strikes. An estimated 50,000 to 60,000 Americans are living with the disease, which accounts for about 10 to 20 percent of all dementia cases. Although the age of onset ranges from 21 to 80, most FTD cases occur between the ages of 45 and 64. FTD has a substantially greater impact on work and finances than Alzheimer’s, often upending families in midlife when careers are still active, children may be at home and financial safety nets like Medicare are not yet available. ​

“Early symptoms are frequently subtle or mistaken for stress, depression, marital conflict or psychiatric illness,” says Susan Dickinson, CEO,  The Association for Frontotemporal Degeneration. Dickinson adds that a once-reliable family member may begin making poor financial decisions, acting socially inappropriately or losing empathy, all without recognizing that anything is wrong. “This lack of insight, itself a hallmark of frontal-lobe damage, often delays diagnosis and can cause lasting damage to relationships before families understand what is happening.”​

Can medical research unlock new treatment options?

There is currently no cure for FTD, and unlike Alzheimer’s, which now has several FDA-approved medications that can help manage symptoms or modestly slow cognitive and functional decline, there are no treatments available to slow or stop FTD’s progression. Compounding this challenge, FTD is a diagnosis made based upon symptom checklists for behavioral or language subtypes as there is no validated blood test, or biomarker, specifically associated with FTD.​

“People with FTD are often first diagnosed with a psychiatric condition because the earliest and most visible symptoms reflect changes in behavior, personality and emotion, rather than memory or physical function,” says Dr. Ryan Darby, director of the Vanderbilt Frontotemporal Dementia Clinic and associate professor of neurology at Vanderbilt University Medical Center in Nashville. “These symptoms can also be present in depression, bipolar disorder and other psychiatric conditions.”​

Diagnosis still relies on a combination of brain imaging showing atrophy in key brain areas, detailed neuropsychological testing and, in some cases, genetic testing in symptomatic patients to identify genetic forms.​

About one-fifth of people with FTD have an underlying genetic cause in more than a dozen genes. One of the most common is the GRN gene, which disrupts production of progranulin, a protein essential for brain cell survival, and can trigger the neurodegenerative process. Several research programs are investigating how gene supplementation could deliver a working copy of the GRN gene directly to the brain to slow, halt or alter FTD symptoms. ​

"This is one of the few forms of dementia where we understand the root cause at a molecular level," says Dr. David Cooper, chief medical officer at AviadoBio, one of several companies studying how gene therapy may impact FTD. "Gene therapy gives us a chance to intervene before more brain cells are lost, rather than chasing the damage after it's already occurred." ​

two people standing in a bedroom
Debra and Kevin Rhodes in Nashua, New Hampshire. "Because he still looks and sounds like himself, people don't always see what I'm managing behind the scenes," says Debra.
Jesse Burke

How FTD impacts caregivers

For Kevin and Debra Rhodes, the earliest signs showed up in Kevin’s performance at work. Once highly motivated and successful in health care technology sales, Kevin unexpectedly lost a series of jobs in his late 50s, exhibiting increasing disorganization, poor judgment and uncharacteristic impulsivity. After Debra and their daughter alerted their primary care physician to what they were witnessing, a neurological referral led to answers, nearly three years after the symptoms started.​

“FTD didn’t just change Kevin’s behavior, it changed the entire rhythm of our lives,” says Debra of Nashua, New Hampshire. “One day I was his wife, and the next I was managing finances, decisions and safety, all while trying to protect his dignity and the man he’s always been.”​

For caregivers, FTD presents distinct and demanding challenges, yet the profound lack of support for those caring for people with the disease is often overlooked. Individuals may appear physically healthy and capable, even as their judgment deteriorates, complicating safety and supervision. Spouses are often the first to notice changes, only to be met with confusion, misdiagnosis or referral to marriage counseling rather than neurology. “Because Kevin still looks and sounds like himself, people don’t always see what I’m managing behind the scenes,” adds Debra. “Living with FTD means constantly walking a fine line, honoring his independence while knowing that, sometimes, I have to be the only adult in the room.”​

Rita B. Choula, senior director of caregiving at the AARP Public Policy Institute, knows these challenges well. She spent more than a decade caring for her mother, Theresa Bryant, who lived with behavioral variant FTD (bvFTD), a lesser-known, often misdiagnosed form of early-onset dementia. Initially told her mother had Alzheimer’s, Choula questioned the diagnosis after noticing striking changes in her mom’s personality and behavior. Bryant was ultimately diagnosed with bvFTD at age 60 and passed away at 72.​

Choula recalls how her once outgoing, empathetic mother gradually withdrew from social interaction and lost the emotional awareness that had long defined her. One of the defining moments was when Choula had her first child.

“Mom came to the hospital with my sister and appeared expressionless while holding her granddaughter for the first time— no joy, laughter or affection toward me or her first grandchild.” For Choula, this lack of emotion was deeply painful and confusing, especially since her mother was undiagnosed at the time.

Join Our Fight for Caregivers

Here’s how you can help:

The long and challenging journey to an accurate diagnosis shaped Choula’s commitment to improving awareness, support and advocacy for families affected by FTD. Choula, who serves on the board of The Association for Frontotemporal Degeneration, shares practical guidance for caregivers navigating this complex and frequently misunderstood disease.​

1. Trust what you are seeing

FTD is frequently misdiagnosed, often taking two to three years for a clinical diagnosis. Choula emphasized that caregivers usually notice changes long before clinicians do. Abrupt shifts in personality, empathy, judgment or behavior that don’t fit a mental health diagnosis should be documented and raised repeatedly with health care providers.​

2. Advocate persistently for an accurate diagnosis

Choula stresses the importance of continuing to push for neurological evaluation when symptoms escalate or don’t align with psychiatric explanations, emphasizing that reassessing the diagnosis in light of new or atypical signs is essential to preventing misdiagnosis and delayed treatment.​

3. Behavioral symptoms are often the most distressing, not memory loss

​In behavioral variant FTD, memory may remain intact early on, while empathy, emotional connection and social awareness fade. “For caregivers, the loss of emotional awareness, especially during milestones like childbirth or family celebrations, can be profoundly painful,” explains Choula.​

4. Find an FTD specialist

​Look for neurologists or memory specialists at major academic medical centers or dementia research programs, as they often have FTD expertise. Organizations like t The Association for Frontotemporal Degeneration can also provide referrals to clinicians who specialize in FTD care. While you may need to travel farther to access these specialists, the quality of care your loved one receives is typically much higher.​

5. FTD creates unique challenges for couples and families

​Personality changes from FTD can deeply affect family dynamics and marriages, especially when someone who was once warm, empathetic and engaged becomes withdrawn, impulsive or emotionally detached. “A spouse might struggle with a partner who makes uncharacteristic social blunders, loses empathy or no longer shares affection, while children or siblings may feel confused, hurt or rejected,” says Choula. Caregivers need to remember that these behaviors are symptoms of the disease itself, not reflections of the person’s intentions or feelings, and that adjusting expectations and seeking support can help families navigate these unexpected shifts.​

6. Memory care facilities are often a poor fit

​Most dementia care environments are designed around memory loss, not behavioral symptoms. Choula noted that families frequently struggle to find in-home aides, group homes or memory care units with trained staff to support people with FTD, especially younger individuals. When identifying long-term care facilities, Choula recommends that caregivers ask the staff how they care for residents who may show more behavioral symptoms than memory loss, and how do they support residents who are younger and more physically capable.

generic-video-poster

Unlock Access to AARP Members Edition

Join AARP to Continue

Already a Member?

Red AARP membership card displayed at an angle

Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine.